Sharon Bio-Medicine is currently trading at Rs. 31.55, up by 1.95 points or 6.59% from its previous closing of Rs. 29.60 on the BSE.
The scrip opened at Rs. 32.55 and has touched a high and low of Rs. 32.55 and Rs. 31.25 respectively. So far 224016 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 45.45 on 16-Dec-2014 and a 52 week low of Rs. 12.45 on 06-Jul-2015.
Last one week high and low of the scrip stood at Rs. 32.55 and Rs. 24.65 respectively. The current market cap of the company is Rs. 352.05 crore.
The promoters holding in the company stood at 59.51% while Institutions and Non-Institutions held 5.24% and 35.25% respectively.
Sharon Bio-Medicine has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) conducted in August 2015 at its formulation manufacturing plant located at Central Hope Town, Sellaqui Industrial Estate, Dehradun.
The company’s another plant located at Taloja has also been inspected by the USFDA officials and outcome of the inspection is awaited.
Sharon Bio-Medicine is into manufacturing and supply of Active Pharmaceutical Ingredients (APIs).
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |